Skip to main content
Home
Menu
Main menu
  • About us
  • Entrepreneurs
  • Advisers
  • Investors
  • Portfolio
  • Jobs
  • News
  • Client login
  • Client login
  • UK
  • US

£3.6m increase in student spending gives ICS Learn its best-ever year

14 February 2017

The Daily Record reports on the success of ICS Learn.

News

  • Newsletter sign-up
  • Forthcoming events

Our numbers1

361
Investment rounds

Our awards

EIS Impact Award 2022 - Winner
Par Equity was recognised for its highly impactful investment and eventual realisation of Current Health, which was sold in October 2021 for $400m, making it Europe's second largest digital health exit ever.
Par Equity LLP
3A Dublin Meuse
Edinburgh, EH3 6NW

Contact us

info@parequity.com

+44 (0)131 556 0044

  • UK
  • US

This is the Par Equity UK website

Find us
  • Terms of Use and Disclaimers
  • Privacy Policy
  • Cyber Essentials Plus Certified
  • Cookies

© 2022 Par Equity. Par Fund Management Limited (FRN 485668) is authorised and regulated by the Financial Conduct Authority.

1 As at 31st March 2022. Past performance should not be seen as an indication of future performance and any references to past or forecasted performance should not be relied upon as a guarantee of future returns.